The Jurkat cell line is a human T lymphocyte cell line that is extensively used in immunological research and for studying the mechanisms of cell signaling, particularly those related to apoptosis. The introduction of the GFP reporter gene into Jurkat cells allows for the visualization of cellular processes, such as protein localization, cell division, and the response to various stimuli. GFP serves as a non-invasive marker that can be observed in living cells, providing real-time information on cellular dynamics.
The GFP reporter cell line in Jurkat cells is a valuable tool for studying the effects of genetic modifications or pharmacological interventions on T cell behavior. It is particularly useful for investigating the role of T cells in immune responses and the development of targeted therapies for diseases such as cancer and autoimmune disorders.
The αβ T cell receptor (TCR) is a receptor expressed on the surface of αβ T cells that recognizes antigens presented by major histocompatibility complex (MHC) molecules and triggers T cell immune responses. The researchers established a Jurkat cell line with a double knockout of TCRαβ and expressing CD8αβ molecules. After large-scale TCR sequencing of activation marker-positive CD8 T cells by NGS, reverse TCR cloning was performed using unique CDR3-specific PCR primers to directly obtain functional TCRs. The researchers successfully amplified 15 TCRα and 14 TCRβ chains from cDNA of 4-1BB-positive CD8 T cells restricted to HLA-A*02:01, HLA-A*02:06, HLA-B*07:02, and HLA-B*40:06. A panel of these TCRα and TCRβ gene combinations was studied using Jurkat reporter cell lines and artificial antigen-presenting cells (APCs). Their specificity and affinity were confirmed in two TCR pairs restricted by HLA-A*02:01, one TCR pair restricted by HLA-A*02:06, four TCR pairs restricted by HLA-B*07:02, and one TCR pair restricted by HLA-B*40:06. The TCR pairs of HLA-A*02:01/1-1 showed alloreactivity to HLA-A*02:06. One TCR pair showed a higher response to the naturally processed antigen than the peptide library. This reverse TCR cloning system not only provides functional information for NGS, but will also help in the development of TCR-T therapies.
Figure 1. Jurkat cells were cultured in RPMI-1640 medium and grown and detected in a 37°C, 5% CO2 environment. CD8αβ molecules and NFκB reporter systems were stably expressed by transducing lentivirus containing CD8β-T2A-CD8α and NFκB transcriptional reporter systems. After flow cytometry analysis and single-cell clone screening, Jurkat cell clones (J8G clones) expressing high levels of CD8αβ and GFP were finally obtained. (Hong CH, et al., 2022)
The GFP Reporter Cell Line - Jurkat offers versatile applications in immunological research and beyond. Jurkat cells, derived from human T lymphocytes, serve as a model system for studying immune responses and cellular signaling events. Incorporating the green fluorescent protein (GFP) reporter into Jurkat cells enhances their utility by allowing real-time visualization and quantification of cellular processes.
(1)Immunophenotyping and Cell Sorting: GFP Reporter Cell Line - Jurkat facilitates the identification and isolation of specific T cell subsets based on GFP expression patterns. Flow cytometry analysis coupled with GFP fluorescence enables precise immunophenotyping, contributing to the characterization of immune cell populations in health and disease.
(2)Investigating T Cell Activation and Function: Researchers utilize GFP Reporter Cell Line - Jurkat to investigate T cell activation dynamics and effector functions in response to various stimuli, including antigens, cytokines, and immune modulators. Monitoring GFP expression provides insights into intracellular signaling pathways and regulatory mechanisms governing T cell activation.
(3)Drug Discovery Targeting T Cell Signaling: GFP Reporter Cell Line - Jurkat serves as a valuable tool for screening and evaluating compounds targeting T cell signaling pathways. High-throughput assays utilizing this cell line enable the rapid assessment of drug effects on T cell activation, proliferation, and cytokine production, facilitating the development of immunomodulatory therapeutics.
Customer Q&As
What are the specific applications of the GFP Reporter Cell Line - Jurkat in studying the dynamics of gene expression in real-time during T cell activation?
A: The GFP Reporter Cell Line - Jurkat can be used to visually track the activation of T cells by monitoring the changes in GFP fluorescence, which correlates with the expression levels of genes of interest. This allows researchers to study the temporal dynamics of gene expression in response to various stimuli, such as antigen presentation or cytokine exposure, providing insights into the complex signaling pathways involved in T cell activation.
How can the GFP Reporter Cell Line - Jurkat be employed to investigate the effects of epigenetic modifications on gene regulation in leukemic T cells?
A: By introducing specific epigenetic modifiers or inhibitors into the GFP Reporter Cell Line - Jurkat, researchers can assess how these modifications affect the expression of genes controlled by the GFP reporter. This approach enables the study of histone modifications, DNA methylation, and other epigenetic changes in the context of T cell leukemia and their impact on gene regulation.
In the context of immunotherapy, how can the GFP Reporter Cell Line - Jurkat be utilized to screen for compounds that modulate T cell receptor signaling pathways?
A: The cell line can be used in high-throughput screening assays to identify small molecules or biologics that affect T cell receptor (TCR) signaling. By monitoring changes in GFP fluorescence upon TCR stimulation, researchers can evaluate the efficacy of potential therapeutics in modulating T cell responses, which is crucial for the development of targeted immunotherapies for various diseases, including cancer.
What role does the GFP Reporter Cell Line - Jurkat play in understanding the molecular mechanisms of T cell apoptosis and its implications in immune homeostasis?
A: The cell line can be used to study the molecular pathways leading to T cell apoptosis by introducing genes or compounds that induce cell death. The GFP reporter can serve as a marker to monitor the progression of apoptosis, allowing researchers to investigate the balance between pro-apoptotic and anti-apoptotic factors and their role in maintaining immune homeostasis.
How can researchers use the GFP Reporter Cell Line - Jurkat to model the interaction between T cells and human immunodeficiency virus (HIV) infection?
A: The Jurkat cell line, being a T cell line, can be infected with HIV to study the virus's interaction with T cells. The GFP reporter can be used to track the effects of HIV infection on T cell gene expression and function, providing insights into the molecular mechanisms of HIV pathogenesis and the host's immune response to the virus. This can aid in the development of therapeutic strategies to combat HIV infection.
Ask a Question
Customer Reviews
Immunological Model Insight
The GFP Reporter Cell Line - Jurkat is derived from a human T cell leukemia line, providing an excellent model for immunological research. This cell line allows us to study T cell behaviors and signaling pathways.
High Transfection Efficiency
Jurkat cells are known for their high transfection efficiency, meaning that the GFP Reporter Cell Line - Jurkat readily takes up foreign DNA. This feature is beneficial for genetic manipulation and studying gene function.
Rapid Proliferation Rate
This cell line proliferates rapidly, facilitating quick experimental turnaround. Fast growth enables timely studies and efficient use of research resources when working with the GFP Reporter Cell Line - Jurkat.
Suspension Culture Adaptability
Unlike adherent cell lines, the GFP Reporter Cell Line - Jurkat grows in suspension, which simplifies scaling up cultures and performing cell-based assays without the need for detachment processes.
Write a Review